OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS Pharmaceutical Group Inc. under contract SPE2DP26F3436 for the delivery of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, under the master delivery order SPE2DX25D9900. The award was issued on July 21, 2026, and the total contract value is specified in the official award documentation. This procurement is a federal transaction managed by the Department of Defense, with no set-aside classification indicated. The item is intended for government use, and performance is expected to support military or defense healthcare needs. All details regarding delivery, quantities, and payment terms are contained within the associated award documents accessible via the provided DIBBS link.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
